TITLE

Urological problems in Parkinson's disease: clinical aspects

AUTHOR(S)
Jost, Wolfgang
PUB. DATE
April 2013
SOURCE
Journal of Neural Transmission;Apr2013, Vol. 120 Issue 4, p587
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Bladder dysfunctions are quite common in Parkinson's disease. They may occur at any stage of the illness and get worse with advancing and aggravating disease. The most prominent dysfunction is the so-called overactive bladder. Control of bladder function is part of a highly complex system subject to the interaction of predominantly the frontal and pontine micturition or continence center and the spinal cord. Besides there are some other anatomic structures involved in the complex control loop of bladder regulation. Regarding central regulation, dopamine is the essential neurotransmitter that inhibits bladder activity. All dopaminergic substances are capable of influencing automatic control systems. This also holds true for many other classes of other medications such as anticholinergics, antidepressants, and beta-blockers. The chief clinical problem of this patient consists in reduced inhibition with consequentially resulting overactivity of the detrusor muscle, meaning the urge to urinate in the absence of adequate bladder filling. The patients mostly complain of an imperative urge to urinate, of pollakisuria, nocturia and even incontinence of urine (urge incontinence). The objectives of diagnosis and therapy focus on controlled bladder evacuation and continence of urine. The most important diagnostic clues are provided by the patient's medical history. Only in rare cases urodynamic studies are indicated as well. For treatment we can avail ourselves of a number of anticholinergic drugs. We must watch out though that the medication ordered is not going to impact on cognition.We recommend tolteradine, not passing the blood brain barrier, or M3-specific antimuscarinics such as solifenacin and darifenacin. Positive therapeutic outcomes are limited. A new alternative at hand, albeit not approved for the time being, is the local injection of botulinum toxin into the detrusor muscle.
ACCESSION #
86418905

 

Related Articles

  • The value of uroflow in evaluating LUTS (Lower Urinary Tract Symptoms) in men; ten years of experience. Manu-Marin, A.; R. Neamtu; Calomfirescu, N.; Neamtu, M.; Vesa, L.; Belinski, C.; Neicutescu, C. // Romanian Journal of Urology;Sep2009, Vol. 8 Issue 3, p14 

    Introduction & Objectives: The scope of this article is to review the technique of uroflow, the definitions of the ICS (International Continence Society), the data that are a must in results presentation, and the artifacts that can influence the results. Uroflowmetry is a noninvasive test to...

  • Mesh retraction correlates with vaginal pain and overactive bladder symptoms after anterior vaginal mesh repair: comment on Rogowski et al. Jacquetin, B. // International Urogynecology Journal;May2014, Vol. 25 Issue 5, p703 

    A letter to the editor is presented in response to the article "Mesh retraction correlates with vaginal pain and overactive bladder symptoms after anterior vaginal mesh repair" by A. Rogowski and colleagues published in an issue of the International Urogynecology Journal & Pelvic Floor Dysfunction."

  • OnabotulinumtoxinA for Idiopathic Overactive Bladder. Rovner, Eric S.; Koski, Michelle // AUANews;Oct2012, p25 

    The article discusses onabotulinumtoxinA or Botox as a possible option for idiopathic overactive bladder. It references the study "OnabotulinumtoxinA for Urinary Incontinence in Patients With Idiopathic Overactive Bladder: Results of a Phase 3 Pivotal Trial" by V. W. Nitti, presented at the May...

  • Micturition in Göttingen minipigs: first reference in vivo data for urological research and review of literature. Huppertz, N. D.; Tolba, R. H.; Grosse, J. O. // Laboratory Animals;Oct2015, Vol. 49 Issue 4, p336 

    One possible symptom of overactive bladder (OAB) is urinary incontinence, which is generally considered to be an age-associated disease and which is rapidly increasing with demographic changes. Rodent models are commonly used for the investigation of lower urinary tract functions, although the...

  • An unusual use of AMS 800 artificial urinary sphincter cuff in the treatment of sphincteric neurogenic incontinence: case report. Siracusano, S; Ciciliato, S; Benedetto, P Di; Marega, D; Tiberio, A; Stacul, F // Spinal Cord;Nov2004, Vol. 42 Issue 11, p652 

    STUDY DESIGN::Case report of an unusual use of AMS 800 (American Medical Systems, Inc., Minnetonka, Minnesota) artificial urinary sphincter cuff in a female patient affected by neurogenic urinary incontinence. OBJECTIVE::To describe this rare surgical solution. SETTING::Department of Urology in...

  • Rupture and perforation of urinary reservoirs made from bowel. Singh, Sadmeet; Choong, Simon // World Journal of Urology;Aug2004, Vol. 22 Issue 3, p222 

    A review of the literature involving the rupture or perforation of urinary reservoirs made from the bowel indicates that this complication is perhaps not as rare as commonly perceived. It is a severe complication for which a high index of suspicion needs to be maintained. Physicians attending to...

  • Don't Allow Overactive Bladder to Compromise Your Quality of Life.  // Women's Health Advisor;Aug2014, Vol. 18 Issue 8, p4 

    The article discusses the causes of overactive bladder (OAB) in women and also mentions that behavioral modifications and medications can reduce the symptoms of urinary urgency and frequency. Topics discussed include role of neurological disorders such as Parkinson's disease and bladder cancer...

  • New Developments in Urology: Urology Update 2014. Herschorn, Sender // Canadian Urological Association Journal;Jan/Feb2015 Supplement, Vol. 9 Issue 1/2, pS1 

    An introduction to the journal is presented in which the editor discusses topics related to urology including importance of detecting and treating high-risk prostate cancer (PCa), guidelines on overactive bladder (OAB) and pediatric augmentation cystoplasty.

  • Novel Drug Works for Refractory OAB.  // Renal & Urology News;Apr2012, Vol. 11 Issue 4, p12 

    The article focuses on the study led by Vik Khullar which shows that micturition and incontinence episodes can be reduced by mirabegron, an experimental drug for overactive bladder (AOB) regardless of prior antimuscarinic therapy.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics